Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Site Stability To Be Discussed By Panel, Possible Adv. Cmte. Meeting

This article was originally published in The Tan Sheet

Executive Summary

An expert panel to discuss site-specific stability is being formed by FDA in response to concerns expressed by the drug industry, Center for Drug Evaluation & Research Deputy Director for Pharmaceutical Sciences Roger Williams stated at the NDMA Manufacturing Controls Seminar in Philadelphia Oct. 8-9.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088986

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel